BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38618280)

  • 1. Unveiling the Mechanism of the ChaiShao Shugan Formula Against Triple-Negative Breast Cancer.
    Fan T; Huang Y; Liu Z; Huang J; Ke B; Rong Y; Qiu H; Zhang B
    Drug Des Devel Ther; 2024; 18():1115-1131. PubMed ID: 38618280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of Bazhen decoction in the treatment of colorectal cancer based on network pharmacology, molecular docking, and experimental validation.
    Lu S; Sun X; Zhou Z; Tang H; Xiao R; Lv Q; Wang B; Qu J; Yu J; Sun F; Deng Z; Tian Y; Li C; Yang Z; Yang P; Rao B
    Front Immunol; 2023; 14():1235575. PubMed ID: 37799727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systems Network Pharmacology-Based Prediction and Analysis of Potential Targets and Pharmacological Mechanism of
    Hu Y; Yang L; Lu Y; Wang Y; Jiang J; Liu Y; Cao Q
    Evid Based Complement Alternat Med; 2022; 2022():2116006. PubMed ID: 36193154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtual screening of the multi-gene regulatory molecular mechanism of Si-Wu-tang against non-triple-negative breast cancer based on network pharmacology combined with experimental validation.
    Zhang Z; Liu J; Liu Y; Shi D; He Y; Zhao P
    J Ethnopharmacol; 2021 Apr; 269():113696. PubMed ID: 33358854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration of the sensitization effect of Chaihu Shugan powder on chemotherapy for triple-negative breast cancer and its active ingredients.
    Wei W; Li X; Li Z
    Biopolymers; 2024 Jun; ():e23605. PubMed ID: 38864249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
    Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
    Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanism of oroxyli semen against triple-negative breast cancer verified by bioinformatics and in vitro experiments.
    Chen L; Yang A; Li Y; Liu X; Jiang W; Hu K
    Medicine (Baltimore); 2023 Sep; 102(37):e34835. PubMed ID: 37713894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of Epimedium in the treatment of coronary atherosclerotic heart disease based on network pharmacology, molecular docking, and in vitro studies.
    Xin G; Yuedong Y; Xuemei S; Chenhan M; Meng Z; Chenbo Z; Ning G; Xindong W
    Eur Rev Med Pharmacol Sci; 2022 Apr; 26(7):2478-2488. PubMed ID: 35442463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A real-world study and network pharmacology analysis of EGFR-TKIs combined with ZLJT to delay drug resistance in advanced lung adenocarcinoma.
    Han X; Liang L; He C; Ren Q; Su J; Cao L; Zheng J
    BMC Complement Med Ther; 2023 Nov; 23(1):422. PubMed ID: 37990309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding apoptotic induction by Sargentodoxa cuneata-Patrinia villosa herb pair via PI3K/AKT/mTOR signalling in colorectal cancer cells using network pharmacology and cellular studies.
    Mu BX; Li Y; Ye N; Liu S; Zou X; Qian J; Wu C; Zhuang Y; Chen M; Zhou JY
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117342. PubMed ID: 37879505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanism of Ruxian Shuhou prescription in the treatment of triple-negative breast cancer based on network pharmacology.
    Chu M; Meng T; Zhou Y; Jin L; Dai Q; Ma L; Chen H
    Medicine (Baltimore); 2023 Sep; 102(35):e34763. PubMed ID: 37657065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploration of the Pharmacological Mechanism of Vitexicarpin against Triple-Negative Breast Cancer in Network Pharmacology.
    Wu T; Xiang M; Li Y; Gao Y; Teng D; Sun M; Guo W; Zhou Y
    Front Biosci (Landmark Ed); 2023 Dec; 28(12):341. PubMed ID: 38179762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Network pharmacology to explore the molecular mechanisms of Prunella vulgaris for treating thyroid cancer.
    Zhang Z; Zhou J; Guo R; Zhou Q; Wang L; Xiang X; Ge S; Cui Z
    Medicine (Baltimore); 2023 Nov; 102(45):e34871. PubMed ID: 37960775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the mechanism of Xiaoqinglong decoction in the treatment of infantile asthma based on network pharmacology and molecular docking.
    Chen D; Chen Q; Zhao K; Guo Y; Huang Y; Yuan Z; Cai Y; Li S; Xu J; Lin X
    Medicine (Baltimore); 2023 Jan; 102(2):e32623. PubMed ID: 36637916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bioinformatics analysis of quercetin in octagonal lotus for the screening of breast cancer MYC, CXCL10, CXCL11, and E2F1.
    Ma Y; Peng Z; Pan R; Zhu Z; Meng X; Hu H; Qiao X; Huang X; Hou M
    Int J Immunopathol Pharmacol; 2021; 35():20587384211040903. PubMed ID: 34693792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network Pharmacology and Experimental Validation to Explore the Effect and Mechanism of Kanglaite Injection Against Triple-Negative Breast Cancer.
    Zhao M; Fu L; Xu P; Wang T; Li P
    Drug Des Devel Ther; 2023; 17():901-917. PubMed ID: 36998242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer.
    Yang X; Li F; Shi Y; Wu Y; Yang R; Liu X; Zhang Y; Zhang G; Ma M; Luo Z; Han X; Xie Y; Liu S
    Acta Biochim Biophys Sin (Shanghai); 2024 May; 56(5):763-775. PubMed ID: 38516703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the mechanism and experimental validation of Fuzi Lizhong Tang in treating gastric cancer based on network pharmacology and molecular docking.
    Zhang FY; Guo SC
    Eur Rev Med Pharmacol Sci; 2023 Oct; 27(19):9192-9204. PubMed ID: 37843333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Network pharmacology integrated with molecular docking technology to reveal the potential mechanism of Shuganfang against drug-induced liver injury.
    Wang Y; Chen X; Wang Y; Zhong H; Liu L; Ye Y
    Medicine (Baltimore); 2023 Dec; 102(48):e36349. PubMed ID: 38050247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of Danlou tablet on myocardial ischemia/ reperfusion injury assessed by network pharmacology and experimental verification.
    Ye Y; Xiaoyang C; Junkai Y; Yueyao HU; Wei W
    J Tradit Chin Med; 2024 Feb; 44(1):131-144. PubMed ID: 38213248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.